| EPB023 | Global availability of skin biopsy for the diagnosis of Kaposi sarcoma in HIV treatment settings | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB024 | Evaluation of a rapid multiplex assay based digital screening strategy in Canada: what's the verdict? | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB025 | Syndemics in people newly diagnosed with HIV in Manitoba, Canada. Importance of coinfections and comorbidities | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB026 | Low utilization of TB-LAM for TB screening among children under five with advanced HIV disease in Uganda: a descriptive analysis of surveillance data | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB027 | Diagnostic performance of HbA1c, fasting blood glucose, and the oral glucose tolerance test among people with HIV | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB028 | Health related quality of life is impaired in people living with HIV and hepatic steatosis | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB029 | Improved tuberculosis case finding among patients with Advanced HIV Disease in Nigeria through the deployment of a point of care tuberculosis diagnostic test | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB030 | Adopting a Continuous Quality Improvement (CQI) platform as a real-time performance tracker for improving HIV care and treatment outcomes in Botswana | E-poster | Biomarkers for the prediction of morbidity and mortality |
| EPB031 | Soluble CD27 predicts progression of kidney dysfunction in people living with HIV | E-poster | Biomarkers for the prediction of morbidity and mortality |
| EPB032 | Integrating 3HP-based tuberculosis preventive treatment (TPT) into Zimbabwe's fast track HIV model: aligning TPT and HIV visits, multi-month dispensing, and telephone follow-up were feasible and acceptable | E-poster | Tuberculosis: Prevention, diagnosis, treatment |